See related research by Ploppa *et al.*, <http://ccforum.com/content/14/6/R201>

In the previous issue of *Critical Care*, the report by Ploppa and colleagues reveals an interrelation among neutrophil activation, endothelial cells, platelets and shear forces that may underlie the unwanted accumulation of neutrophils in vascular beds unrelated to the infection site \[[@B1]\].

A hallmark feature of neutrophils is their ability to rapidly accumulate at sites of infection, where they kill invading pathogens through the release of their cytotoxic granule contents, the generation of reactive oxygen species and, under certain critical conditions, the release of enzyme-laden DNA that forms large web-like structures or neutrophil extracellular traps \[[@B2]\]. The movement of neutrophils out of the vasculature into tissues follows a well-described process that involves their weak interaction with the endothelium through selectins and subsequent firm adhesion mediated by integrins \[[@B3]\]. This migration process must be highly controlled, since insufficient numbers of neutrophils in the infectious site results in a failure to control infection, whereas excess neutrophil accumulation may lead to tissue injury.

Studies carried out over the past decade showed that, during sepsis, there is an important dysregulation in neutrophil migration. This is best characterized by an insufficient recruitment of neutrophils to the primary site of infection along with a massive accumulation of neutrophils in distal organs such as the lungs and liver. The clinical relevance of these phenomena is the strong relationship between neutrophils in organs and tissue injury leading to subsequent multiple organ dysfunction, the ultimate cause of death in sepsis \[[@B4],[@B5]\].

The study by Ploppa and colleagues used a simplified *in vitro*flow chamber model and revealed the paradoxical finding that activated neutrophils adhere less well than unstimulated neutrophils to activated endothelium, in part due to shedding of the adhesion molecule L-selectin \[[@B1]\]. Second, these activated neutrophils only adhered firmly to the endothelium when shear was significantly decreased. Third, mimicking the endothelial injury (presumed to occur in sepsis) by exposing the subendothelial matrix led to platelet adhesion that mediated a profound increase in subsequent adherence of activated neutrophils even in the presence of higher shear forces.

The authors then attempted to translate these results to neutrophil behavior in septic patients. The authors postulated that neutrophils, upon activation, would preferentially accumulate in vascular beds with poor perfusion. There is a huge body of work showing that circulating neutrophils are activated by a myriad of proinflammatory mediators during sepsis \[[@B6],[@B7]\]. Whether the disproportionate neutrophil recruitment into, for example, the lungs is due to poor perfusion, whether it is due to the unique geometry of the pulmonary microvasculature or whether it is due to unique adhesive profiles found on lung endothelium, however, remains unclear. Certainly, the limitations of this study include the inability to mimic the geometry of pulmonary capillaries and the use of human umbilical vein endothelium, which differs in a major way from pulmonary endothelium \[[@B8]\]. The authors also postulate that the accumulation of activated neutrophils in vascular beds could trigger massive endothelial damage, exposing the subendothelial matrix to circulating platelets. Consequently, platelets would aggregate at these sites and could mediate further neutrophil accumulation less dependent on shear and more dependent on P-selectin expressed by the platelets. Together, the poorly perfused beds could become sites of preferentially activated neutrophil trapping leading to increased endothelial injury, which would be followed by platelet deposition and further neutrophil accumulation, inducing a vicious cycle that would ultimately lead to loss of organ function.

A strength of this study is the use of human cells, which is not trivial as significant differences exist between humans and mice - even for example in the synthesis of P-selectin, which can occur via NF-κB in rodents but requires completely different cytokines (for example, IL-4) in humans \[[@B3]\]. Mouse experiments can, however, provide important information. For example, neutrophils arrive prior to platelets in some endotoxemic organs, making neutrophil sequestration independent of platelets \[[@B9]\]. Moreover, platelets will bind already adherent neutrophils in the septic milieu and will activate and induce neutrophil extracellular traps, and this does cause massive endothelial injury, highlighting the further complexity of the *in vivo*septic milieu \[[@B10]\]. Moreover it was recently demonstrated that neutrophils in a septic milieu express novel chemokine responsiveness \[[@B7]\] and novel adhesion pathways turning off integrins via IL-10 and activating novel adhesive mechanisms such as CD44/hyaluronan in places such as the liver \[[@B11],[@B12]\]. This begs the question of whether adhesion is different in each and every organ in sepsis \[[@B3]\], making anti-adhesion therapy a less attractive approach.

The report by Ploppa and colleagues reaffirms the general view that even in a simple three-cell *in vitro*system under flow conditions there can be significant complexity underlying neutrophil tracking. However, it is provocative to question whether this is truly dysregulation or a final attempt by the immune system to squelch a systemic infection by setting up neutrophil-platelet road blocks in various vasculatures in an attempt to catch circulating bacteria. Indeed, neutrophil-platelet interactions in sepsis cause the release of neutrophil extracellular traps that trap bacteria in a very effective manner \[[@B10]\]. Clearly, effort is needed to move from these *in vitro*systems to imaging the human vasculature to gain further understanding of this process in order to translate data into increased patient survival in intensive care units.
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